- Latest available (Revised)
- Point in Time (31/10/2019)
- Original (As adopted by EU)
After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.
The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.
Point in time view as at 31/10/2019.
There are outstanding changes not yet made to Council Decision of 20 May 1975 setting up a pharmaceutical committee (75/320/EEC). Any changes that have already been made to the legislation appear in the content and are referenced with annotations.
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
THE COUNCIL OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Economic Community;
Having regard to the proposal from the Commission;
Whereas the implementation of the measures adopted by the Council as regards the approximation of the laws relating to proprietary medicinal products for human use may raise problems which should be jointly examined;
Whereas, to this end, a Committee should be set up, chaired by a representative of the Commission and composed of representatives of the Member States from those States' administrations,
HAS DECIDED AS FOLLOWS:
A Committee called the ‘Pharmaceutical Committee’ shall be set up and attached to the Commission.
Without prejudice to the tasks of the Committee for Proprietary Medicinal Products referred to in Article 8 of the Second Council Directive 75/319/EEC(1) of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products, the task of this Committee shall be to examine:
any question relating to the application of Directives on proprietary medicinal products which are brought up by its Chairman — either on his initiative or at the request of the representative of a Member State;
any other question in the field of proprietary medicinal products brought up by its Chairman — either on his initiative or at the request of the representative of a Member State.
The Commission shall consult the Committee when preparing proposals for Directives in the field of proprietary medicinal products, and in particular when it considers any amendments to Council Directive 65/65/EEC(2) of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products which it might have occasion to propose.
1.The Committee shall consist of senior experts in public health matters from the Member States' administrations and each Member State shall have one representative.
2.There shall be one deputy for each representative. This deputy shall be entitled to participate in meetings of the Committee.
3.A representative of the Commission shall chair the Committee.
The Committee shall adopt its rules of procedure.
Done at Brussels, 20 May 1975.
For the Council
The President
R. Ryan
See page 13 of this Official Journal.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: